These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9811896)

  • 1. c-Myc target gene specificity is determined by a post-DNAbinding mechanism.
    Boyd KE; Wells J; Gutman J; Bartley SM; Farnham PJ
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13887-92. PubMed ID: 9811896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myc versus USF: discrimination at the cad gene is determined by core promoter elements.
    Boyd KE; Farnham PJ
    Mol Cell Biol; 1997 May; 17(5):2529-37. PubMed ID: 9111322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.
    Miltenberger RJ; Sukow KA; Farnham PJ
    Mol Cell Biol; 1995 May; 15(5):2527-35. PubMed ID: 7739536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene.
    Bruno ME; West RB; Schneeman TA; Bresnick EH; Kaetzel CS
    Mol Immunol; 2004 Jan; 40(10):695-708. PubMed ID: 14644095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
    Kiermaier A; Gawn JM; Desbarats L; Saffrich R; Ansorge W; Farrell PJ; Eilers M; Packham G
    Oncogene; 1999 Dec; 18(51):7200-11. PubMed ID: 10602473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM; Farnham PJ
    Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF.
    Lee TC; Ziff EB
    J Biol Chem; 1999 Jan; 274(2):595-606. PubMed ID: 9872993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexamination of site-specific transcription factor binding and promoter activity in living cells.
    Boyd KE; Farnham PJ
    Mol Cell Biol; 1999 Dec; 19(12):8393-9. PubMed ID: 10567564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
    Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
    Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin-yang 1 activates the c-myc promoter.
    Riggs KJ; Saleque S; Wong KK; Merrell KT; Lee JS; Shi Y; Calame K
    Mol Cell Biol; 1993 Dec; 13(12):7487-95. PubMed ID: 8246966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-MYC apoptotic function is mediated by NRF-1 target genes.
    Morrish F; Giedt C; Hockenbery D
    Genes Dev; 2003 Jan; 17(2):240-55. PubMed ID: 12533512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter.
    Veldman T; Liu X; Yuan H; Schlegel R
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8211-6. PubMed ID: 12821782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
    Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
    J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse USF1 gene cloning: comparative organization within the c-myc gene family.
    Henrion AA; Vaulont S; Raymondjean M; Kahn A
    Mamm Genome; 1996 Nov; 7(11):803-9. PubMed ID: 8875887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the human c-myc gene by c-Myb.
    Zobel A; Kalkbrenner F; Vorbrueggen G; Moelling K
    Biochem Biophys Res Commun; 1992 Jul; 186(2):715-22. PubMed ID: 1497659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative properties of the USF family of helix-loop-helix transcription factors.
    Luo X; Sawadogo M
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1308-13. PubMed ID: 8577760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter.
    Eberhardy SR; Farnham PJ
    J Biol Chem; 2002 Oct; 277(42):40156-62. PubMed ID: 12177005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
    Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
    Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms.
    Klenova EM; Nicolas RH; Paterson HF; Carne AF; Heath CM; Goodwin GH; Neiman PE; Lobanenkov VV
    Mol Cell Biol; 1993 Dec; 13(12):7612-24. PubMed ID: 8246978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.